Newscenter Media News Cresomycin, a groundbreaking antibiotic developed by Harvard scientists, targets drug-resistant bacteria with improved binding to ribosomes, offering hope against global antimicrobial resistance. A new antibiotic…
Check Also
Innovators to scramble for $1m investment prize at 2024 Africa Tech Festival
Burgeoning innovators across the continent are set to begin a scramble for the $1,000,000 investment …